SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation

Abstract
Viruses evade the innate immune response by suppressing the production or activity of cytokines such as type I interferons (IFNs). Here we report the discovery of a novel mechanism by which the SARS-CoV-2 virus co-opts an intrinsic cellular machinery to suppress the production of the key immunostimulatory cytokine IFN-β. We reveal that the SARS-CoV-2 encoded Non-Structural Protein 2 (NSP2) directly interacts with the cellular GIGYF2 protein. This interaction enhances the binding of GIGYF2 to the mRNA cap-binding protein 4EHP, thereby repressing the translation of the Ifnb1 mRNA. Depletion of GIGYF2 or 4EHP significantly enhances IFN-β production, leading to reduced viral infection. Our findings reveal a new target for rescuing the antiviral innate immune response to SARS-CoV-2 and other RNA viruses.
Competing Interest Statement
The authors have declared no competing interest.
Footnotes
11 Lead contact: N.S.: (nahum.sonenberg{at}mcgill.ca)
Subject Area
- Biochemistry (7336)
- Bioengineering (5305)
- Bioinformatics (20219)
- Biophysics (9990)
- Cancer Biology (7713)
- Cell Biology (11280)
- Clinical Trials (138)
- Developmental Biology (6426)
- Ecology (9928)
- Epidemiology (2065)
- Evolutionary Biology (13294)
- Genetics (9353)
- Genomics (12564)
- Immunology (7686)
- Microbiology (18979)
- Molecular Biology (7427)
- Neuroscience (40938)
- Paleontology (300)
- Pathology (1226)
- Pharmacology and Toxicology (2132)
- Physiology (3145)
- Plant Biology (6850)
- Synthetic Biology (1893)
- Systems Biology (5306)
- Zoology (1086)